Roche Gets EU Approval for Breast Cancer Drug

EU has approved Kadcyla for use in patients with advanced HER2-positive breast cancer. The drug was approved by U.S. regulators in February.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304791704579209312957903766.html?mod=pls_whats_news_us_business_f

via IFTTT